Nalmefene

CAS No. 55096-26-9

Nalmefene ( —— )

Catalog No. M29645 CAS No. 55096-26-9

Nalmefene is a long acting opioid (MOR and DOR antagonist), and a partial KOR agonist. Nalmefene is used for opioid overdose and alcohol dependence.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG Get Quote In Stock
500MG Get Quote In Stock

Biological Information

  • Product Name
    Nalmefene
  • Note
    Research use only, not for human use.
  • Brief Description
    Nalmefene is a long acting opioid (MOR and DOR antagonist), and a partial KOR agonist. Nalmefene is used for opioid overdose and alcohol dependence.
  • Description
    Nalmefene is a long acting opioid (MOR and DOR antagonist), and a partial KOR agonist. Nalmefene is used for opioid overdose and alcohol dependence.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    Other Targets
  • Recptor
    MOR, DOR, KOR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    55096-26-9
  • Formula Weight
    339.43
  • Molecular Formula
    C21H25NO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O[C@]12[C@@]34C5=C(C[C@@]2([H])N(CC6CC6)CC4)C=CC(O)=C5O[C@@]3([H])C(CC1)=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang DS, et al. Nalmefene: a long-acting opioid antagonist. Clinical applications in emergency medicine. J Emerg Med. 1998 May-Jun;16(3):471-5. 2. Mann K, et al. Nalmefene for the management of alcohol dependence: review on its pharmacology, mechanism of action and meta-analysis on its clinical efficacy. Eur Neuropsychopharmacol. 2016 Dec;26(12):1941-1949.
molnova catalog
related products
  • Meclizine

    Meclizine (Meclozine), an antihistamine, reversibly inhibits the interaction of histamine at the H1 receptors.

  • Phosphoserine

    The phosphoric acid ester of serine.

  • Terazosin

    Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist.